Soros Invested Heavily in Chinese Biotech Research Company with Facility in Wuhan that Researches Respiratory Models and Infectious DiseaseDocuments from the Securities and Exchange Commission in 2011 show Soros Fund Management LLC invested heavily into WUXI Pharmatech Caymen, Inc.
WuXi AppTec, as it is now called, has a facility in Wuhan, China. The company provides validated research including in vitro (HTS, SAR screening support) and in vivo disease models in cardiovascular, respiratory, metabolic and infectious diseases.
The document was filed with the US government in August 2012.